相关实验视频

Updated: Jan 16, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

在接受治疗的糖尿病患者中,心血管风险标志物概况的变化有不同的身体组成

Aratrika Sau¹, Nivedita Nanda¹, Jayaprakash Sahoo²

¹Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.

Journal of family medicine and primary care

|October 3, 2025

概括

高BMI的2型糖尿病患者表现出素和炎症的增加,FABP3.3的降低. 身体脂肪分布,而不仅仅是BMI,更好地解释了糖尿病中的心血管疾病风险.

科学领域:

内分泌学在内分泌学.
代谢综合征是代谢综合征的一种.
心血管疾病研究研究

背景情况:

2型糖尿病 (T2D) 患者面临心血管疾病 (CVD) 风险升高,即使在治疗中.
肥胖是胰岛素抵抗和心血管疾病的一个已知的危险因素.
阿迪普辛和心脏类型脂肪酸结合蛋白 (FABP3) 是与肥胖,胰岛素抵抗,炎症和代谢综合征相关的阿迪波金.

研究的目的:

在T2D患者中调查素,FABP3,炎症和身体组成之间的关联.
用亚洲肥胖标准,将T2D患者的这些标志物与高与正常BMI进行比较.
探索身体脂肪分布在T2D患者心血管疾病风险分层中的作用.

主要方法:

使用ELISA量化阿迪普辛和FABP3水平.
使用数字记录来评估身体组成.
单向ANOVA用于与健康对照进行比较.

主要成果:

与健康对照组相比,高BMI T2D患者表现出显著增加的素和TNF-α,FABP3降低.
具有正常BMI的T2D患者表现出显著的中心肥胖,与较高的素水平相关.
在T2D患者中,FABP3水平与炎症标志物相反相关.

结论:

二型糖尿病患者呈现不同的心血管疾病风险概况,受素和FABP3水平的影响.
身体脂肪分布提供了对心血管疾病风险的更细致的了解,而不是单独在T2D中的BMI.
未来的T2D治疗应该考虑新的标记物和身体成分,以改善结果.

关键词:

动脉样硬化是一种动脉样硬化.心脏代谢标志物心脏代谢标志物肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

相关概念视频

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...